Avrupa Kardiyoloji Derneği Miyokart Revaskülarizasyonu Kılavuzu 2014 güncellemesi ne yenilikler getirdi?

Kaynakça (9)

1. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascula- rization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Develo- ped with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619
2. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55
3. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bu- eno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting wit- hout persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054
4. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lund- qvist C, Borger MA, et al. ESC Guidelines for the manage- ment of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619
5. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the ma- nagement of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003
6. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012;41:734-45
7. Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergo- uwe Y, Chieffo A, et al. Anatomical and clinical characteris- tics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013;381:639-50
8. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012;367:2375-84
9. Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FW, et al. Greater clinical benefit of more inten- sive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in thera- peutic outcomes by optimizing platelet inhibition with pra- sugrel-Thrombolysis in Myocardial Infarct